AstraZeneca PLC

AstraZeneca PLC

AstraZeneca is a major international research based pharmaceutical company engaged in the development, manufacture and marketing of ethical (prescription) pharmaceutical products. AstraZeneca's long heritage of innovation and documented ability to develop new concepts in medicine has made us one of the top five pharmaceutical companies in the world.

AstraZeneca PLC is headquartered in London with its U.S. headquarters located in Wilmington, Delaware. Wilmington is also the global home for the company's Central Nervous System (CNS) commercial and research and development efforts.

AstraZeneca operates nine different R&D sites and has sales activities in over 100 countries and manufacturing facilities in 19 countries. AstraZeneca has a workforce of more than 50,000 strong - with over 12,000 employees in the U.S. alone.

Based in Sweden, AstraZeneca's R&D organization is international in scope and comprised of approximately 10,000 researchers. Through its own resources and collaborations with dozens of universities and strategic alliances with numerous research and biotechnology companies, AstraZeneca has broad access to advanced technologies in biomedical research, including genomics, bio informatics, chemical libraries, high throughput screening and product delivery systems.

AstraZeneca's success ratio of bringing new products to market is among the best in the pharmaceutical industry. The company produces a wide range of products that make significant contributions to treatment options and patient care. AstraZeneca has one of the world's leading portfolios to treat cancer and gastrointestinal disorders, in addition to the areas of anesthesia (including pain management), cardiovascular disease, respiratory and central nervous system disorders.

In 1947, AstraZeneca USA, the US subsidiary of Astra AB, was incorporated and began operations in Worcester, Massachusetts. In 1949, AstraZeneca launched XYLOCAINE® (lidocaine HCI), a local anaesthetic, that represented the first of many anaesthesia products to be manufactured by AstraZeneca.

AstraZeneca has a full range of products in six therapeutic areas (gastrointestinal, oncology, anesthesia (including pain management), cardiovascular, central nervous system (CNS) and respiratory), which treat conditions and diseases ranging from asthma to gastroesophageal reflux disease to heart disease.

Source: www.astrazeneca-us.com

Login or Register (for FREE) to search and buy a checkSURE Company Credit Report on AstraZeneca PLC